Back to search
Internuclear Ophthalmoplegia
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Internuclear Ophthalmoplegia trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Internuclear Ophthalmoplegia trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
Internuclear ophthalmoplegia is a symptom frequently associated with multiple sclerosis (MS), although other etiologies are possible. Some patients do not meet…
Rationale: Clemastine fumarate has been identified as potential remyelinating therapy for multiple sclerosis (MS). The (long-term) effects of clemastine need to…